Amy Miller, MD
Ophthalmology · Dayton, OHNPI 1205864519
Payments from drug & device makers
Across 636 payments — averaging $827.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$215K
- Aerie Pharmaceuticals, Inc.$140K
- AbbVie$79K
- Harrow Eye, LLC$78K
- Glaukos Corporation$11K
- Bausch & Lomb Americas Inc.$1K
- plus $1K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 219 | $215,203 |
| Aerie Pharmaceuticals, Inc. | 145 | $140,035 |
| AbbVie(2 entities) | 136 | $79,292 |
| Harrow Eye, LLC | 47 | $77,783 |
| Glaukos Corporation | 12 | $11,377 |
| Bausch & Lomb Americas Inc. | 17 | $1,301 |
| Novartis | 20 | $330 |
| Ivantis, Inc | 3 | $244 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $202 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $131 |
| Oyster Point Pharma, Inc. | 6 | $104 |
| Sun Pharmaceutical Industries Inc. | 3 | $61 |
| Thea Pharma Inc. | 2 | $45 |
| Biotissue Holdings Inc. | 2 | $34 |
| Tarsus Pharmaceuticals, Inc. | 1 | $32 |
| Eyevance Pharmaceuticals LLC | 2 | $31 |
| Alimera Sciences, Inc. | 1 | $30 |
| Cepheid | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Johnson & Johnson Vision Care, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Shire North American Group Inc | 1 | $17 |
| NEW World Medical,inc. | 1 | $12 |
| Kala Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$526,401 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Dayton
- Patrick SpencerDayton$471K
- Kevin WattDayton$68K
- Kunalkumar VyasDayton$20K
- John PajkaLima$17.7M
- Justis EhlersCleveland$5M
- Lawrence SingermanBeachwood$3.9M
- Sunil SrivastavaCleveland$2.8M
- Daniel MillerCincinnati$2.3M
- Jonathan LassCleveland$1.9M
- William WileyCleveland$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.